[1] |
HAO Xiao, ZHAO Mei, WANG Wenjing, ZHANG Feifei, LIU Huiliang, DANG Yi, LI Shuren, QI Xiaoyong.
Application of sodium-glucose cotransporter 2 inhibitors in acute myocardial infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 824-831.
|
[2] |
CHEN Jiayin, WANG Li, WANG Lijun, TONG Gangling, MA Jie, CHEN Xijing, LU Yang.
Correlation between organic cation transporter gene polymorphisms and the toxicities and clinical response of oxaliplatin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 171-177.
|
[3] |
PAN Rongrong, ZHI Yinghao, JIN Yongxi, ZHOU Xiahui.
Influences of theaflavins on neuronal apoptosis and blood-brain barrier in rats with cerebral hemorrhage by regulating CaMKK2/AMPK signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1240-1246.
|
[4] |
FAN Wenxiang, ZHANG JinLu, XU Chi.
Research progress of α7 nicotinic acetylcholine receptors in central nervous system diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 1065-1072.
|
[5] |
LIU Lu, CHEN Xiaoyan.
Current status of clinical drug-drug interactions research of innovative small molecule drugs in China
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 863-875.
|
[6] |
ZHOU Han, LIU Xiaodong.
Application of physiologically based pharmacokinetic model in drug development and several questions being thought
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 889-913.
|
[7] |
SUN Rensong, ZHANG Jianbin, FANG Jiani, LYU Xia, TANG Zeyao, TIAN Yan.
Application of chitosan nanoparticle served as drug delivery system for cancer therapy#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 65-75.
|
[8] |
LIU Yan, LIU Jiali, JIA Yuanwei, ZHOU Fang, WANG Guangji, ZHANG Jingwei.
Advances in the evaluation of intra-tumoral delivery of antitumor drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(10): 1151-1159.
|
[9] |
SHAN Xiaolei, FU Shujun, GAO Guanghua, SUN Tao, WANG Qingli, YU Shanshan.
Metabolism- and transporter-mediated drug-drug interaction-overview of in vitro study and cases analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(10): 1165-1171.
|
[10] |
DU Juan, XU Lingyan, WU Wei, SHENG Qingqing, JIANG Zhenzhou, ZHANG Luyong, HUANG Xin.
Changes of transporters expression and activity in rheumatoid arthritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(2): 223-229.
|
[11] |
CHEN Dan, GUO Yujin, YANG Mengqi, CA Hualin, JIANG Pei.
Advances in studies of neurotoxicity of angiotensin(1-7)
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(12): 1425-1430.
|
[12] |
TENG Yi, YANG Hai-ling.
Research progress on the pharmacokinetic profile of borneol
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(4): 469-475.
|
[13] |
WANG Xin-shi, FANG Hui-lin, ZHU Zhen-guo, ZHU Pan, ZENG Qing-yi, ZHENG Rong-yuan.
Effect of idazoxan on the tight junctions of blood-brain barrier in mouse experimental autoimmune encephalomyelitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(2): 138-144.
|
[14] |
LIU Yu, GAO Rui, CHEN Yu, CHEN Lin, XIA Chun-hua, DENG Guo-fang.
Study progress on anti-tuberculosis drug-induced liver damage associated with drug-metabolizing enzyme gene polymorphism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(1): 91-95.
|
[15] |
LIU Li, GUO Chen-xian, PENG Jin-fu, HUANG Jie, YANG Guo-ping.
Development of microRNA-dependment control of drug transporter
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 1064-1068.
|